Amato, L., Rosa, C. D., Guida, G. D., Sepe, F., Ariano, A., Capaldo, S., . . . Morgillo, F. Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients. Nature Publishing Group.
Chicago Style (17th ed.) CitationAmato, Luisa, et al. Addition of Metformin to Anti-PD-1/PD-L1 Drugs Activates Anti-tumor Immune Response in Peripheral Immune Cells of NSCLC Patients. Nature Publishing Group.
MLA (9th ed.) CitationAmato, Luisa, et al. Addition of Metformin to Anti-PD-1/PD-L1 Drugs Activates Anti-tumor Immune Response in Peripheral Immune Cells of NSCLC Patients. Nature Publishing Group.
Warning: These citations may not always be 100% accurate.